Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study.
Hodgkin lymphoma
developing country
real-world evidence
relapsed/refractory
treatment outcome
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
pubmed:
7
10
2022
medline:
26
1
2023
entrez:
6
10
2022
Statut:
ppublish
Résumé
Information on Hodgkin lymphoma (HL) is mostly limited to Europe and North America. This real-world, retrospective study assessed treatment pathways and clinical outcomes in adults with stage IIB-IV classical HL receiving frontline treatment (
Identifiants
pubmed: 36200380
doi: 10.1080/10428194.2022.2126281
doi:
Substances chimiques
Cisplatin
Q20Q21Q62J
Cytarabine
04079A1RDZ
Etoposide
6PLQ3CP4P3
Banques de données
ClinicalTrials.gov
['NCT03327571']
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM